A Study of a Urine Test to Detect Colorectal Cancer
Recruiting · NCT07649057 · Observational (researchers observe without assigning treatment)
View the official record on ClinicalTrials.gov →Interventions studied
3-metabolite biosensor
What this trial is about
The purpose of this study is to find out whether a urine test can detect colorectal cancer (CRC) and precancerous polyps in participants living in Ghana, Tanzania, and South Africa.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Patient presents with one of the following:
- Patients with symptoms of CRC (such as rectal bleeding for a week) -OR-
- Patients who present for a screening colonoscopy -OR-
- Has received one of the following within 3 weeks of the planned urine collection
- Patients with a pathologic diagnosis of CRC either by colonoscopy or resection specimens -OR-
- Patients with colonoscopy demonstrating adenomatous polyps -OR-
- Patients with colonoscopy demonstrating no colon or premalignant or malignant pathology
- Age ≥ 18
- Willingness to participate in the study
Where it is running
4 locations listed across 1 US state.
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York, New York, United States
- Korle Bu Teaching Hospital (Data Collection Only) - Accra, Ghana
- Wits Donald Gordon Medical Centre (Data Collection Only) - Johannesburg, South Africa
- Kilimanjaro Christian Medical Centre (Data Collection Only) - Moshi, Tanzania